Stacey B. Daughters, Ph.D.

Background Information:

Dr. Daughters received her PhD in Clinical Psychology after completing her Clinical Internship in the Brown University Clinical Psychology Training Consortium and Center for Alcohol and Addiction Studies. She is currently an Assistant Professor and Director of the Stress, Health, and Addiction Research Program (SHARP) in the Department of Behavioral and Community Health, faculty in the Program in Neuroscience and Cognitive Science, and affiliated faculty in the Clinical Psychology program. Dr. Daughters' research interests include understanding the interaction of neurobiological and behavioral determinants of stress and addiction, and the translation of this knowledge into effective prevention and intervention programs. She is the recipient of multiple NIH funded grants, the 2006 College on Problems of Drug Dependence Early Career Investigator Award, and a three year Visiting Professor fellowship from the Center for AIDS Prevention Studies (CAPS) at the University of California, San Francisco. Dr. Daughters mentors doctoral students in the Department of Behavioral and Community Health as well as the Program in Neuroscience and Cognitive Science (NACS).

Representative Publications

Daughters, S.B., Magidson, J.M., Schuster, R.M., & Safren, S. (2010). ACT HEALTHY: A combined cognitive-behavioral depression and medication adherence treatment for HIV-infected substance users. Cognitive and Behavioral Practice , 309-321.

Daughters, S.B., Richards, J.M., Gorka, S., & Sinha, R. (2009). HPA axis response to psychological stress is predictive of treatment retention in residential substance abuse treatment. Drug and Alcohol Dependence, 105, 202-208 .

Daughters, S.B., Reynolds, E.K., MacPherson, L., et al. (2009). Distress tolerance and early adolescent externalizing and internalizing symptoms: The moderating role of gender and ethnicity. Behaviour Research and Therapy , 198-205.

Daughters, S.B., Braun, A.R., Sargeant, M.N., et al., (2008). Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The Life Enhancement Treatment for Substance Use (LETS ACT!). The Journal of Clinical Psychiatry , 69, 122-129.

Daughters, S.B., Lejuez, C.W., Bornovalova, M.A., Kahler, C., Strong, D., & Brown, R. (2005). Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. Journal of Abnormal Psychology , 114, 729-734.

GRANTS (currently funded)

Depression Treatment for Urban Low Income Minority Substance Users
Role: Principal Investigator
Agency, Type, and Number: National Institute on Drug Abuse R01 DA 026424
Total Project Period: 4/1/10-3/30/15
Overall Goal: To conduct a randomized control trial with long term outcome data for the Life Enhancement Treatment for Substance Use (Let's Act)

Behavioral Depression Treatment for African American HIV-infected Substance Users
Role: Principal Investigator
Agency, Type, and Number: National Institute on Drug Abuse R01 DA022974
Period: 9/1/08 - 8/30/12
Overall Goal: To develop and test the effectiveness of an integrated treatment to improve medication adherence and decrease depressive symptoms and sexual risk taking behavior among low income urban HIV positive substance users.

GRANTS ( under review )

Identification of Neural Indices of Distress Intolerance using fMRI
Role: Principal Investigator
Agency, Type, and Number: NIDA R21 DA029221-01 (Priority score = 20)
Total Project Period: 2 Years
Overall Goal: Examination of neural circuitry associated with distress intolerance among cocaine users.